Ionis Pharmaceuticals Inc (IONS)
38.76
+0.37
(+0.96%)
USD |
NASDAQ |
Nov 01, 16:00
38.76
0.00 (0.00%)
After-Hours: 20:00
Ionis Pharmaceuticals Max Drawdown (5Y): 70.27% for Oct. 31, 2024
Max Drawdown (5Y) Chart
Historical Max Drawdown (5Y) Data
| Date | Value |
|---|---|
| October 31, 2024 | 70.27% |
| September 30, 2024 | 70.27% |
| August 31, 2024 | 70.27% |
| July 31, 2024 | 70.27% |
| June 30, 2024 | 70.27% |
| May 31, 2024 | 70.27% |
| April 30, 2024 | 70.27% |
| March 31, 2024 | 70.27% |
| February 29, 2024 | 70.27% |
| January 31, 2024 | 70.27% |
| December 31, 2023 | 70.27% |
| November 30, 2023 | 70.27% |
| October 31, 2023 | 70.27% |
| September 30, 2023 | 70.27% |
| August 31, 2023 | 70.27% |
| July 31, 2023 | 70.27% |
| June 30, 2023 | 70.27% |
| May 31, 2023 | 70.27% |
| April 30, 2023 | 70.27% |
| March 31, 2023 | 70.27% |
| February 28, 2023 | 70.27% |
| January 31, 2023 | 70.27% |
| December 31, 2022 | 70.27% |
| November 30, 2022 | 70.27% |
| October 31, 2022 | 70.27% |
| Date | Value |
|---|---|
| September 30, 2022 | 70.27% |
| August 31, 2022 | 70.27% |
| July 31, 2022 | 70.27% |
| June 30, 2022 | 70.27% |
| May 31, 2022 | 70.27% |
| April 30, 2022 | 70.27% |
| March 31, 2022 | 70.27% |
| February 28, 2022 | 70.27% |
| January 31, 2022 | 70.27% |
| December 31, 2021 | 70.27% |
| November 30, 2021 | 69.24% |
| October 31, 2021 | 65.39% |
| September 30, 2021 | 61.06% |
| August 31, 2021 | 64.97% |
| July 31, 2021 | 66.67% |
| June 30, 2021 | 66.67% |
| May 31, 2021 | 66.67% |
| April 30, 2021 | 68.24% |
| March 31, 2021 | 73.25% |
| February 28, 2021 | 73.25% |
| January 31, 2021 | 73.25% |
| December 31, 2020 | 73.25% |
| November 30, 2020 | 73.25% |
| October 31, 2020 | 73.25% |
| September 30, 2020 | 73.25% |
Max Drawdown Definition
Max drawdown is an indicator of the risk of a portfolio chosen based on a certain strategy. It measures the largest single drop from peak to bottom in the value of a portfolio before a new peak is achieved.
Max Drawdown (5Y) Range, Past 5 Years
61.06%
Minimum
Sep 2021
73.25%
Maximum
Nov 2019
70.56%
Average
70.27%
Median
Dec 2021
Max Drawdown (5Y) Benchmarks
| Biogen Inc | 58.04% |
| Alnylam Pharmaceuticals Inc | 42.46% |
| Biomarin Pharmaceutical Inc | 52.14% |
| Rigel Pharmaceuticals Inc | 86.40% |
| Apellis Pharmaceuticals Inc | 74.65% |
Max Drawdown (5Y) Related Metrics
| Alpha (5Y) | -14.60 |
| Beta (5Y) | 0.3919 |
| Annualized Standard Deviation of Monthly Returns (5Y Lookback) | 34.69% |
| Historical Sharpe Ratio (5Y) | -0.2751 |
| Historical Sortino (5Y) | -0.4771 |
| Monthly Value at Risk (VaR) 5% (5Y Lookback) | 16.26% |